SP-MHCI-0917-3

Human GTPase KRas 7-15, VVVGAVGVGK

US$507.00

In stock

Description

About Human GTPase KRas 7-15, VVVGAVGVGK

The Human GTPase KRas (mutated sequence of VVVGAGGVG) Peptide (IEDB: 1309312) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The GTPase KRas Peptide, H-VVVGAVGVGK-OH (Uniprot: P01116 aa: 7-15) from JPT is produced under strict quality control and quality management.

Human GTPase KRas 7-15, VVVGAVGVGK - Specifications

  • Peptide sequence: H-VVVGAVGVGK-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Adenocarcinoma
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human GTPase KRas 7-15, VVVGAVGVGK

References:
Read References with JPT’s Antigen Peptides
Human GTPase KRas 7-15, VVVGAVGVGK has been described in:
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors., Cancer Immunol Res, 2016 (PMID: 26701267)
Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells., Cancer Immunol Immunother, 2023 (PMID: 36436020)
Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides., J Immunother Cancer, 2024 (PMID: 38631707)

Documentation

Documentation for Human GTPase KRas 7-15, VVVGAVGVGK

Properties

Properties of Human GTPase KRas 7-15, VVVGAVGVGK

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Adenocarcinoma
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: GTPase KRas
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human GTPase KRas 7-15, VVVGAVGVGK

Information Values
Sequence: H-VVVGAVGVGK-OH
WT Sequence: VVVGAGGVG
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote